Neuralink's N1 device, aiming to restore mobility and vision, could impact millions. Neuralink is not publicly traded, limiting direct investment opportunities. Invest indirectly via Alphabet ...

Elon Musk says Neuralink's Brain-Chip Interface Blindsight implant will undergo first clinical trial in 2026 in UAE.

Elon Musk’s Neuralink suggests a human patient may have successfully used its brain chip to control a robotic arm. A video ...

In a February blog post, Neuralink said: "Our work has shown encouraging potential for the Link to help restore autonomy to individuals with significant mobility impairments. Over the past year ...

but not yet for their physical mobility to come back, offering a massive improvement to their conditions. Elon Musk and Neuralink are promising paraplegics a chance to live better lives with the ...

Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device." The company is developing the technology in an attempt to restore ...

Brad Smith, an Arizona husband and father with ALS, has become the third person to receive Neuralink, the brain implant made by Elon Musk’s company.

(Reuters) -Neuralink has received the U.S. Food and Drug Administration's "breakthrough" tag for its device to restore communication for individuals with severe speech impairment, Elon Musk's ...

The third human to receive a Neuralink brain implant, who also has non-verbal ALS, is now able to speak in his own voice thanks to the advancing technology combined with Artificial Intelligence (AI).

Neuralink indicates that in the future it aims to "restore capabilities such as vision, motor function, and speech, and eventually expand how we experience the world." Arbaugh has previously ...